Home  >  News
Msc_Jun22 Advertisement
you can get e-magazine links on WhatsApp. Click here
  EMA committee recommends approval of argenx’s efgartigimod to generalized myasthenia gravis,   June 25, 2022
  China NMPA approves intravenous formulation of Cresemba to treat invasive aspergillosis and invasive mucormycosis,   June 25, 2022
  Merck’s Keytruda gets European approval as adjuvant treatment for adult and adolescent patients with stage IIB or IIC melanoma following complete resection,   June 25, 2022
  US FDA clears Fusion Pharma’s IND for FPI-2059, an investigational small molecule-based radiopharmaceutical targeting solid tumours expressing NTSR1,   June 24, 2022
  US FDA granted accelerated approval to Novartis’ Tafinlar + Mekinist for first tumour-agnostic indication for BRAF V600E solid tumours,   June 24, 2022
  Krystal Biotech seeks US FDA approval for B-VEC to treat patients with dystrophic epidermolysis bullosa,   June 24, 2022
  Daiichi Sankyo announces EMA validates Type II Variation application for trastuzumab deruxtecan for patients with HER2 low metastatic breast cancer with HR positive and HR negative disease,   June 23, 2022
  Bayer’s rivaroxaban receives Japanese approval to treat patients with PAD after revascularisation,   June 23, 2022
  Novartis gets European approval for Tabrecta to treat METex14 skipping advanced non-small cell lung cancer,   June 23, 2022
  China NMPA approves Tyvyt in combo with chemotherapy to treat esophageal squamous cell carcinoma,   June 22, 2022
  EMA grants orphan designation to Midatech Pharma’s MTX110 to treat glioma,   June 22, 2022
  Cystic Fibrosis Foundation invests $6 million in Carbon Biosciences to advance new gene therapy approach for CF,   June 22, 2022
  US FDA approves AbbVie’s interleukin-23 inhibitor, Skyrizi to treat moderately to severely active Crohn's disease,   June 21, 2022
  Onward Therapeutics makes a strategic investment in Emercell for NK cell technology for immunotherapy,   June 21, 2022
  Japanese MHLW approves Solasia’s organoarsenic drug, Darvias injection to treat relapsed or refractory PTCL,   June 21, 2022
  Valneva, Pfizer ink equity subscription agreement and update terms of collaboration pact for Lyme disease vaccine candidate VLA15,   June 21, 2022
  US FDA committee votes against approval of Acadia Pharma’s pimavanserin to treat Alzheimer’s disease psychosis,   June 20, 2022
  ExCellThera submits Type II Drug Master File for UM171 with US FDA,   June 20, 2022
  Basilea Pharma tiggers Cresemba sales milestone payment in Asia Pacific region from Pfizer,   June 18, 2022
  UK MHRA joins international partnerships to set global standards for medicines and medical devices regulation,   June 18, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |